Christopher R. Cline
CHIEF FINANCIAL OFFICER · 2 filings · Latest: May 4, 2026
Travere Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
TVTX | Christopher R. Cline | CHIEF FINANCIAL OFFICER | May 6, 2026 | Sale | $43.95 | 310 | $13.6K | 118,658 | |
TVTX | Christopher R. Cline | CHIEF FINANCIAL OFFICER | May 5, 2026 | Sale | $46.65 | 2,181 | $101.7K | 118,968 | |
TVTX | Christopher R. Cline | CHIEF FINANCIAL OFFICER | May 4, 2026 | Option Exercise | $0.00 | 4,250 | — | 121,149 | |
TVTX | Christopher R. Cline | CHIEF FINANCIAL OFFICER | Apr 15, 2026 | Sale | $42.61 | 1,014 | $43.2K | 116,899 | |
TVTX | Christopher R. Cline | CHIEF FINANCIAL OFFICER | Apr 14, 2026 | Sale | $41.93 | 7,248 | $303.9K | 117,913 | |
TVTX | Christopher R. Cline | CHIEF FINANCIAL OFFICER | Apr 13, 2026 | Sale | $28.85 | 65 | $1.9K | 125,161 | |
TVTX | Christopher R. Cline | CHIEF FINANCIAL OFFICER | Apr 13, 2026 | Grant/Award | $0.00 | 14,000 | — | 125,226 |